MHMarten Anne Hoeksema

Marten Anne Hoeksema

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Marten Anne Hoeksema has a total of 340 co-authors. Here are the top co-authors by number of shared publications:

  • Menno P. J. de Winther

    Department of Medical Biochemistry, University of Amsterdam, Amsterdam UMC, Location AMC, Meibergdreef 9, Amsterdam, The Netherlands

    20 shared publications
  • Jan Van Den Bossche

    Department of Molecular Cell Biology and Immunology, Amsterdam Cardiovascular Sciences, Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam Institute for Infection and Immunity, Cancer Centre Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands

    11 shared publications
  • Christopher K. Glass

    Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA, USA

    9 shared publications
  • Saskia van der Velden

    Department of Experimental Immunohematology, Sanquin Research, and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands

    8 shared publications
  • Annette E. Neele

    Experimental Vascular Biology, Medical Biochemistry, Academic Medical Center, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands

    7 shared publications
  • Christopher K. Glass

    Department of Cellular and Molecular Medicine, School of Medicine, University of California, San Diego, La Jolla, CA, USA

    6 shared publications

Latest Publications

  • H3K9 demethylase KDM3A potentiates interferon signaling and macrophage-driven inflammation in atherosclerosis

    by Ricky Siebeler, Hung-Jen Chen, Tatyana Kuznetsova, Annette E. Neele, Saskia van der Velden, Marion J. J. Gijbels, Guillermo R. Griffith, Cindy P. A. A. van Roomen, Koen H. M. Prange, Marieke C. S. Boshuizen, et al.

    Macrophages drive atherosclerosis through inflammatory activation programs shaped by metabolic and epigenetic reprogramming. H3K9 methylation enforces heterochromatin states and represses transcription, whereas removal of this histone modification creates transcriptionally permissive chromatin. Here, we identified KDM3A-mediated H3K9 demethylation to enhance chromatin accessibility at interferon (IFN) signaling loci, thereby promoting IFN production and downstream IFN-dependent transcriptional and chemokine responses. In a mouse model of atherosclerosis, hematopoietic Kdm3a deficiency reduces lesion size, necrotic core formation, and neutrophil recruitment. Mechanistically, Kdm3a -deficient macrophages show impaired chemokine secretion and reduced neutrophil recruitment both in vitro and in vivo. In primary human macrophages, KDM3A knockdown suppressed IFN responses; consistently KDM3A-dependent gene signatures were enriched in IFN-inducible macrophages within human atherosclerotic plaques, and computational modeling predicted a shift toward more stable plaque phenotypes upon KDM3A inhibition. Together, these findings establish KDM3A as an epigenetic regulator that sustains IFN-driven macrophage activation and promotes progression of atherosclerosis, nominating KDM3A as a potential target for selectively modulating IFN-dependent inflammation.

  • Open Access

    A non-canonical EZH2/TRIM28 epigenetic axis drives heparan sulfate remodeling and melanoma metastasis

    by Neil G. Patel, Alexandra Drakaki, Farhan Valummel, Jack C. Moore, Amrita Basu, Bin Hu, Xiaolin Dong, Peng Zhao, Mees Botman, Emily Spector, et al.

    Melanoma progression is driven not only by oncogenic alterations but also by epigenetic programs that remodel the tumor microenvironment. Heparan sulfate (HS) proteoglycans are extracellular matrix components that control growth factor signaling and cell-matrix interactions, yet how chromatin-associated factors regulate HS remodeling in cancer remains ill-defined. Here, we identify the histone methyltransferase EZH2 as a regulator of HS biosynthesis in melanoma. Bioinformatic and genomic analyses reveal enrichment of EZH2 and additional Polycomb Repressive Complex (PRC) factors at regulatory regions of HS biosynthetic genes. CRISPR-mediated loss of EZH2 modulates expression of multiple HS-modifying enzymes, notably the secreted endosulfatases SULF1 and SULF2, enhancing HS 6- O sulfation and altering ligand binding at the cell surface. Unexpectedly, EZH2 promotes SULF1 through a methyltransferase-independent, non-canonical interaction with TRIM28, whereas SULF2 is repressed through canonical PRC2 activity. Functionally, SULF1 depletion impairs melanoma cell migration and invasion and reduces spontaneous metastasis in vivo. These findings define an epigenetic axis linking chromatin regulation to glycan remodeling and identify HS-modifying enzymes as candidate targets to limit melanoma metastasis.

  • Open Access

    Protocol To Study Co-Occupancy of Transcription Factors Using Rechip-Seq in Mouse Macrophages

    by Marten Anne Hoeksema, Mees Botman, Josje M.A. Huisman

    SummarySequential chromatin immunoprecipitation followed by sequencing (reChIP-seq) enables genome-wide mapping of transcription factor (TF) co-occupancy on the same chromatin fragments. In contrast to conventional ChIP-seq, overlapping TF binding profiles do not necessarily reflect simultaneous binding events. Here, we describe a reChIP-seq protocol to identify genomic regions co-occupied by STAT1 and STAT3 in mouse bone marrow-derived macrophages. The workflow can be readily adapted to study other TF combinations and cell types.

  • Open Access

    Multi-level transcriptional control of specific macrophage responses

    by Alexandra Drakaki, Josje M A Huisman, Marten A Hoeksema

    Macrophages can adopt diverse functional states in response to environmental cues, a process that is fundamentally controlled at the level of transcriptional regulation. In this review, we outline a hierarchical framework of transcription factor activity that underpins macrophage identity and activation. Firstly, lineage-determining transcription factors establish the cell-type-specific chromatin landscape during development. Upon tissue seeding, local signals shape the activity of additional transcription factors that refine enhancer landscapes and drive tissue-specific macrophage phenotypes. Macrophages further adopt their functional states when exposed to potential threats to tissue homeostasis, such as bacterial ligands or inflammatory cytokines. In response, signal-dependent transcription factors are activated and initiate signal-appropriate transcriptional programs. The specificity and durability of these responses are determined by secondary transcription factors that modulate the magnitude, timing, and maintenance of stimulus-induced transcriptional programs. Collectively, macrophage responses emerge from the activity of interconnected layers of cell-type-, tissue-, and signal-dependent transcription factors, forming complex regulatory networks that inflict stimulus-specific outcomes. Dysregulation of these networks can transcriptionally rewire macrophages toward disease-associated states. Delineating transcriptional regulators that distinguish signal responses may enable more targeted disease interventions.

  • Open Access

    Nuclear receptor Nur77 resolves the inflammatory response of macrophages primarily by regulating expression of AP-1 transcription factors and their target genes

    by Sanne C Lith, Sebastian Gregoricchio, Claudia M van Tiel, Ingeborg van der Made, Beatriz M Freire, Simon Linder, Sanne Jacobs, Onno Bleijerveld, Liesbeth Hoekman, Guglielmo L Alonzo, et al.

    The nuclear receptor Nur77 plays a crucial, protective role in chronic inflammatory diseases and deficiency of Nur77 in macrophages results in excessive pro-inflammatory cytokine secretion. Previous research suggested that Nur77’s regulatory function in inflammation is due to repression of the pro-inflammatory transcription factor NF-kB, but the underlying mechanism remains unclear. To address this, we applied a genome-wide, multi-omics approach in LPS-stimulated RAW264.7 macrophages with inducible Nur77 expression. Key findings were validated in wild-type and Nur77-deficient bone marrow-derived macrophages. We show that Nur77 suppresses the expression of inflammatory genes through a dual mechanism wherein Nur77 acts as a repressor of AP-1 targets at two levels: first, Nur77 occupies regulatory elements proximal to AP-1 target genes through AP-1 motifs and second, Nur77 regulates the expression of AP-1 family members themselves. These repressive activities of Nur77 result in diminished RNA Pol II on AP-1 genes and their targets. The first zinc finger of the Nur77 DNA-binding domain is required to reduce AP-1 activity. In summary, Nur77 represses macrophage inflammation through regulation of both immediate-early AP-1 expression, as well as inhibition of AP-1-driven gene programs.


  • Transcriptional and chromatin dynamics in macrophage differentiation and activation

    by Marten A. Hoeksema, Annette E. Neele, Koen H. M. Prange, Christopher K. Glass, Menno P. J. de Winther

    The differentiation and functional responses of macrophages are shaped by developmental origin, tissue environment, and local inflammatory cues. These signals converge on transcriptional and chromatin-based regulatory mechanisms that establish macrophage identity and enable rapid adaptation to changing local contexts. Lineage-determining transcription factors drive cellular identity by laying out a cell-specific enhancer landscape, whereas signal-dependent transcription factors control local specialization and responses to microbial products and cytokines. Chromatin organization is critical in establishing the plasticity and memory that macrophages show. Chromatin-modifying enzymes are essential regulators of the dynamic programs that control macrophages by erasing, writing, and reading epigenetic marks underlying the cellular programs. In this Review, we highlight recent advances in our understanding of the transcriptional and chromatin dynamics governing macrophage differentiation, specialization, and activation and discuss their roles in health and disease.


  • Open Access

    Cytokine specificity in macrophages: JAK-STAT and beyond

    by Josje M.A. Huisman, Alexandra Drakaki, Thomas Decker, Marten A. Hoeksema


  • Open Access

    Revealing an unconventional JAK1/2-STAT3 branch in macrophage IFN-γ signaling

    by Mees Botman, Josje M.A. Huisman, Alexandra Drakaki, Sanne L. Maas, Agnieszka Witalisz-Siepracka, Dagmar Stoiber, Emiel P.C. van der Vorst, Ricky Siebeler, Marten A. Hoeksema


  • Open Access

    A non-canonical EZH2/TRIM28 epigenetic axis drives heparan sulfate remodeling and melanoma metastasis

    by Neil G. Patel, Alexandra Drakaki, Farhan Valummel, Jack C. Moore, Amrita Basu, Bin Hu, Xiaolin Dong, Peng Zhao, Mees Botman, Emily Spector, et al.

    Melanoma progression and metastasis are driven not only by oncogenic alterations but also by epigenetic programs that dynamically remodel the tumor microenvironment. Heparan sulfate (HS) proteoglycans are key extracellular matrix components that integrate growth factor signaling, cell-matrix interactions, and migratory behavior by controlling ligand availability and receptor engagement, yet how chromatin-associated factors regulate HS remodeling in cancer remains poorly defined. Here, we identify the histone methyltransferase EZH2 as a key regulator of HS biosynthesis in melanoma. Integrated bioinformatic and genomic analyses revealed enrichment of EZH2 and additional Polycomb Repressive Complex (PRC) factors at regulatory regions of HS biosynthetic genes. CRISPR-mediated loss of EZH2 altered expression of multiple HS-modifying enzymes, most notably the secreted endosulfatases SULF1 and SULF2, resulting in enhanced HS 6- O sulfation and altered ligand binding at the cell surface. Unexpectedly, EZH2 promoted SULF1 expression through a methyltransferase-independent mechanism via a non-canonical interaction with TRIM28, whereas SULF2 was regulated through canonical PRC2-mediated repression. Functionally, SULF1 depletion impaired melanoma cell migration and invasion in vitro and reduced spontaneous metastasis in an orthotopic xenograft model. Together, these findings define an epigenetic axis linking chromatin regulation to extracellular glycan remodeling and identify HS-modifying enzymes as candidate targets to limit melanoma metastasis.